The Urgent Need for Sustainable Aviation Fuels

Aviation contributes roughly 2.5% of global carbon dioxide emissions, and the International Air Transport Association projects that air travel demand will double by 2037. Without a shift away from fossil-derived kerosene, the sector’s climate impact will grow sharply. Sustainable aviation fuels (SAF) offer the most direct route to decarbonize air transport because they can be used in existing engines and infrastructure. Among the various SAF production pathways, microbial biotechnology stands out for its ability to convert widely available renewable feedstocks into drop‑in jet fuel molecules with high precision.

Microbial processes have long been employed to produce ethanol, pharmaceuticals, and industrial chemicals. Adapting these biological systems to generate long‑chain hydrocarbons suitable for jet engines is a natural extension of the field. The resulting fuels are chemically identical to petroleum‑based kerosene, meaning they can be blended with conventional Jet A‑1 and require no engine modifications. This compatibility is a critical advantage for airlines and airframe manufacturers seeking rapid adoption.

Fundamentals of Microbial Biotechnology for Fuel Production

Microbial biotechnology harnesses the metabolic capabilities of bacteria, yeast, and microalgae to synthesize target compounds. In the context of bio‑jet fuels, microorganisms are engineered to divert their natural carbon flux away from cellular growth and toward the accumulation of fatty acids, terpenes, or other hydrocarbon precursors. These intermediates are then chemically processed into the final fuel blendstock. The core advantage lies in the ability to use renewable biomass—agricultural residues, municipal solid waste, or even captured CO₂—as the carbon source, thereby creating a circular carbon economy for aviation.

Key Metabolic Pathways

Two primary metabolic routes dominate microbial jet fuel production. The fatty acid biosynthesis pathway produces free fatty acids that can be hydrolyzed, decarboxylated, or hydrogenated to yield linear alkanes in the C8–C16 range. The isoprenoid pathway (also known as the mevalonate or non‑mevalonate pathway) generates terpenes such as farnesene and bisabolene, which can be saturated to form jet‑range hydrocarbons. Both pathways have been successfully engineered in industrial hosts like Escherichia coli, Saccharomyces cerevisiae, and oleaginous yeasts such as Yarrowia lipolytica.

Preferred Microbial Chassis

  • E. coli: Fast growth, well‑characterized genetics, and extensive synthetic biology tools make it a common platform for proof‑of‑concept studies. However, its low tolerance to high concentrations of hydrocarbons and need for complex media can limit industrial scalability.
  • S. cerevisiae: Robust, high‑ethanol‑tolerance yeast that naturally produces ergosterol (an isoprenoid). Genetic engineering has enabled it to secrete farnesene at commercial titers.
  • Oleaginous yeasts (e.g., Yarrowia lipolytica): Naturally accumulate large quantities of lipids (over 50% of dry weight) and can be engineered to produce tailored fatty acid profiles suitable for jet fuel.
  • Microalgae (e.g., Botryococcus braunii): Some strains naturally secrete long‑chain hydrocarbons, but low growth rates and difficulty in harvesting have slowed commercialization.

Feedstocks and Fermentation Processes

The sustainability of microbial bio‑jet fuels depends heavily on the feedstock. First‑generation feedstocks such as sugarcane and corn compete with food production and are not viable at scale. Current research emphasizes second‑generation feedstocks: lignocellulosic biomass (corn stover, switchgrass, wood chips), municipal solid waste, and industrial waste gases (CO, CO₂, H₂). These materials are pretreated to release sugars or syngas, which are then fed to the microorganisms in aerobic or anaerobic fermentation vessels.

Process optimization focuses on achieving high product titers (typically >50 g/L), high yield (grams of hydrocarbon per gram of substrate), and high productivity (grams per liter per hour). Aerobic processes require significant energy for aeration and heat removal, pushing industry toward anaerobic or micro‑aerobic designs. Some companies, such as LanzaTech, use a gas‑fermentation platform in which acetogenic bacteria convert industrial off‑gases directly into ethanol or other intermediates that can be upgraded to jet fuel.

From Fermentation to Fuel: Downstream Processing

Once the microorganisms have accumulated the target hydrocarbons (free fatty acids, terpenes, or short‑chain alcohols), the mixture is harvested and subjected to chemical upgrading. For lipid‑based routes, the oil is extracted (either through mechanical pressing, solvent extraction, or in‑situ separation using engineered secretion), then transesterified or hydrotreated. Hydrotreating removes oxygen and saturates double bonds, producing straight‑chain and branched alkanes. The resulting product — known as hydroprocessed esters and fatty acids (HEFA) — is a drop‑in blendstock for jet fuel.

For isoprenoid routes, farnesene or bisabolene are hydrogenated over a metal catalyst to yield farnesane or bisabolane, which are fully saturated cyclic or linear hydrocarbons. These must be blended with aromatics (often sourced from other processes) to meet aviation fuel specifications for seal swelling and lubricity. The final blend must pass ASTM D7566 certification before it can be used commercially. Currently, several microbial‑derived pathways have received ASTM approval, including alcohol‑to‑jet (ATJ) from isobutanol and direct sugar‑to‑hydrocarbon (DSHC) from farnesene.

Advantages Over Conventional and Other Biojet Routes

Environmental Benefits

Microbial bio‑jet fuels can achieve life‑cycle greenhouse gas reductions of 60–80% compared to petroleum jet fuel when grown on waste feedstocks. Because the carbon is biogenic (recently fixed from the atmosphere), combustion simply returns CO₂ that was captured during photosynthesis or from industrial point sources. Moreover, certain fermentation processes can be coupled with carbon capture and utilization (CCU), where CO₂ is directly fed to autotrophic microorganisms, resulting in near‑zero or even negative carbon emissions.

Engine Compatibility and Performance

Unlike some biofuel routes that produce oxygenated molecules (e.g., ethanol, butanol) requiring distillation and blending limitations, microbial jet fuel intermediates are hydrocarbon‑based and can be refined to exactly match the specifications of Jet A‑1. They exhibit high energy density (≥42 MJ/kg), low freezing points, and excellent thermal stability. Flight tests conducted by airlines such as United Airlines and Virgin Atlantic have demonstrated that blends containing up to 50% microbial‑derived SAF perform identically to conventional kerosene.

Current Challenges and Research Frontiers

Cost and Scalability

The largest barrier to commercialization is cost. Microbial fermentation today produces bio‑jet fuel at $5–10 per gallon, compared to $2–3 for petroleum kerosene. The high cost arises from feedstock preprocessing, expensive media components (especially nitrogen sources), and capital‑intensive fermentation and downstream equipment. However, as production scales from pilot to commercial facilities (e.g., LanzaTech’s Freedom Pines plant, Gevo’s Luverne facility), economies of learning and process integration are expected to bring costs below $3 per gallon by 2030.

Strain Stability and Productivity

Genetically engineered microbes often suffer from metabolic burden — redirecting carbon to a non‑native product slows growth and can lead to genetic instability. Evolutionary engineering, CRISPR‑based adaptive evolution, and dynamic pathway regulation are being used to create robust strains that maintain high productivity over extended fermentation runs. Additionally, contamination by bacteriophages or competing microorganisms in open systems remains a risk; closed, aseptic fermenters mitigate this but add capital cost.

Product Recovery and Purity

Recovering hydrophobic hydrocarbons from dilute aqueous fermentation broths is energy‑intensive. Traditional processes (centrifugation, solvent extraction) can consume more energy than the fuel product delivers. Membrane separation, in‑situ product removal using non‑toxic adsorbents, and engineered secretion of fuels into an organic overlay are promising approaches. For farnesene production, Amyris developed a two‑phase fermentation where farnesene partitions spontaneously into an oil layer, simplifying recovery.

Commercial Developments and Industry Adoption

Several companies have moved microbial‑derived SAF beyond the laboratory. Gevo produces isobutanol from corn via yeast fermentation, which is then oligomerized and hydrogenated to jet fuel (alcohol‑to‑jet pathway). Its Luverne facility has a nameplate capacity of 10 million gallons per year. LanzaTech operates gas‑fermentation plants that convert steel‑mill off‑gases into ethanol; a portion of that ethanol is upgraded to jet fuel via a partnership with LanzaJet. LanzaJet’s Freedom Pines Fuels plant in Georgia, USA, became the world’s first alcohol‑to‑jet commercial facility in 2023, with targeted output of 10 million gallons of SAF annually. Global Bioenergies (now Deinove) developed a direct isobutene fermentation process, though commercial status remains uncertain.

Regulatory support is accelerating adoption. The U.S. Department of Energy’s Sustainable Aviation Fuel Grand Challenge aims to supply 3 billion gallons of SAF by 2030, with microbial pathways expected to contribute a significant share. The European Union’s ReFuelEU Aviation mandate requires fuel suppliers to blend increasing percentages of SAF (2% in 2025, 70% by 2050), creating a stable market for producers.

Integration with Carbon Capture and Synthetic Biology

Looking ahead, microbial biotechnology for jet fuels will likely converge with two transformative technologies: carbon capture and synthetic biology. Autotrophic microbes (cyanobacteria, acetogens) can directly convert CO₂ and hydrogen into hydrocarbons, eliminating the need for biomass feedstock altogether. Researchers have engineered Synechococcus elongatus to secrete free fatty acids that are then upgraded to jet fuel, though titers remain low. Synthetic biology tools—machine‑learning‑guided enzyme design, genome‑scale metabolic models, and cell‑free systems—are accelerating the optimization of pathways and host organisms.

Another frontier is the use of electricity‑driven processes (electro‑microbial or electro‑fuel). In these systems, renewable electricity generates hydrogen or reduces CO₂ to formate, which microbes then convert to hydrocarbon fuel. Integrated with low‑cost solar or wind power, electro‑microbial pathways could yield jet fuels with near‑zero lifecycle emissions and minimal land use.

Conclusion

Microbial biotechnology provides a versatile and powerful platform for producing sustainable bio‑jet fuels. By engineering microorganisms to convert renewable carbon sources into precise hydrocarbon molecules, the technology can deliver drop‑in fuels that slash aviation’s carbon footprint without sacrificing performance. Economic and technical challenges remain, but rapid progress in strain engineering, process integration, and commercial scaling — supported by regulatory mandates — positions microbial‑derived SAF as a cornerstone of decarbonized aviation. Continued investment in research, infrastructure, and market incentives is essential to bring these fuels to cost parity with fossil kerosene and ensure that air travel can grow sustainably.